424
Views
11
CrossRef citations to date
0
Altmetric
Original Article

Nationwide incidence of motor neuron disease using the French health insurance information system database

, , , &
Pages 426-433 | Received 06 Jan 2017, Accepted 05 Mar 2017, Published online: 07 Apr 2017

References

  • Miller RG, Mitchell JD, Moore DH. Riluzole for amyotrophic lateral sclerosis (ALS)/motor neuron disease (MND). Cochrane Database Syst Rev. 2012;CD001447. Available at: https://www.ncbi.nlm.nih.gov/pubmed/12076411
  • Marin B, Boumediene F, Logroscino G, Couratier P, Babron MC, Leutenegger AL, et al. Variation in worldwide incidence of amyotrophic lateral sclerosis: a meta-analysis. Int J Epidemiol. 2016. Available at: https://www.ncbi.nlm.nih.gov/pubmed/27185810
  • Marin B, Hamidou B, Couratier P, Nicol M, Delzor A, Raymondeau M, et al. Population-based epidemiology of amyotrophic lateral sclerosis (ALS) in an ageing Europe–the French register of ALS in Limousin (FRALim register). Eur J Neurol. 2014;21:1292–300. e78-9.
  • Fang F, Valdimarsdottir U, Bellocco R, Ronnevi LO, Sparen P, Fall K, et al. Amyotrophic lateral sclerosis in Sweden, 1991-2005. Arch Neurol. 2009;66:515–19.
  • Alonso A, Logroscino G, Jick SS, Hernan MA. Incidence and lifetime risk of motor neuron disease in the United Kingdom: a population-based study. Eur J Neurol. 2009;16:745–51.
  • Seals RM, Hansen J, Gredal O, Weisskopf MG. Age-period-cohort analysis of trends in amyotrophic lateral sclerosis in Denmark, 1970-2009. Am J Epidemiol. 2013;178:1265–71.
  • Kioumourtzoglou MA, Seals RM, Himmerslev L, Gredal O, Hansen J, Weisskopf MG. Comparison of diagnoses of amyotrophic lateral sclerosis by use of death certificates and hospital discharge data in the Danish population. Amyotroph Lateral Scler Frontotemporal Degener. 2015;16:224–9.
  • Moulis G, Lapeyre-Mestre M, Palmaro A, Pugnet G, Montastruc JL, Sailler L. French health insurance databases: What interest for medical research? Rev Med Interne. 2015;36:411–17.
  • “Filière de Santé Maladies Rares”-Les centres SLA [18/10/2016]. Available at: http://portail-sla.fr/index.php?option=com_flexicontent&view=category&cid = 9&Itemid = 267
  • Rey G. Death certificate data in France: Production process and main types of analyses. Rev Med Interne. 2016;37:685–93.
  • INSEE. Opération statistique: Estimations de population [22/07/2016]. Available at: http://www.insee.fr/fr/methodes/default.asp?page=sources/ope-adm-estimations-population.htm
  • Besag JYJ, Mollié A. Bayesian image restorationwith applications in spatial statistics. Ann Inst Math Stat. 1991;43:1–20.
  • Richardson S, Thomson A, Best N, Elliott P. Interpreting posterior relative risk estimates in disease-mapping studies. Environ Health Perspect. 2004;112:1016–25.
  • Vaughan AS, Kramer MR, Waller LA, Schieb LJ, Greer S, Casper M. Comparing methods of measuring geographic patterns in temporal trends: an application to county-level heart disease mortality in the United States, 1973 to 2010. Ann Epidemiol. 2015;25:329–35 e3.
  • Forbes RB, Colville S, Parratt J, Swingler RJ. The incidence of motor nueron disease in Scotland. J Neurol. 2007;254:866–9.
  • Chio A, Mora G, Calvo A, Mazzini L, Bottacchi E, Mutani R, et al. Epidemiology of ALS in Italy: a 10-year prospective population-based study. Neurology. 2009;72:725–31.
  • Logroscino G, Beghi E, Zoccolella S, Palagano R, Fraddosio A, Simone IL, et al. Incidence of amyotrophic lateral sclerosis in southern Italy: a population based study. J Neurol Neurosurg Psychiatry. 2005;76:1094–8.
  • Logroscino G, Traynor BJ, Hardiman O, Chio A, Mitchell D, Swingler RJ, et al. Incidence of amyotrophic lateral sclerosis in Europe. J Neurol Neurosurg Psychiatry. 2010;81:385–90.
  • Beghi E, Millul A, Micheli A, Vitelli E, Logroscino G, Group S. Incidence of ALS in Lombardy, Italy. Neurology. 2007;68:141–5.
  • O'Toole O, Traynor BJ, Brennan P, Sheehan C, Frost E, Corr B, et al. Epidemiology and clinical features of amyotrophic lateral sclerosis in Ireland between 1995 and 2004. J Neurol Neurosurg Psychiatry. 2008;79:30–2.
  • Logroscino G, Traynor BJ, Hardiman O, Chio A, Couratier P, Mitchell JD, et al. Descriptive epidemiology of amyotrophic lateral sclerosis: new evidence and unsolved issues. J Neurol Neurosurg Psychiatry. 2008;79:6–11.
  • Ajdacic-Gross V, Schmid M, Tschopp A, Gutzwiller F. Birth cohort effects in neurological diseases: amyotrophic lateral sclerosis, Parkinson's disease and multiple sclerosis. Neuroepidemiology. 2012;38:56–63.
  • Gordon PH, Artaud F, Aouba A, Laurent F, Meininger V, Elbaz A. Changing mortality for motor neuron disease in France (1968-2007): an age-period-cohort analysis. Eur J Epidemiol. 2011;26:729–37.
  • Noonan CW, White MC, Thurman D, Wong LY. Temporal and geographic variation in United States motor neuron disease mortality, 1969-1998. Neurology. 2005;64:1215–21.
  • Marin B, Couratier P, Preux PM, Logroscino G. Can mortality data be used to estimate amyotrophic lateral sclerosis incidence? Neuroepidemiology. 2011;36:29–38.
  • Vasta R, Boumediene F, Couratier P, Nicol M, Nicoletti A, Preux PM, et al. Validity of medico-administrative data related to amyotrophic lateral sclerosis in France: a population-based study. Amyotroph Lateral Scler Frontotemporal Degener. 2017;18:24–31.
  • Lannuzel A, Mecharles S, Tressieres B, Demoly A, Alhendi R, Hedreville-Tablon MA, et al. Clinical varieties and epidemiological aspects of amyotrophic lateral sclerosis in the Caribbean island of Guadeloupe: a new focus of ALS associated with Parkinsonism. Amyotroph Lateral Scler Frontotemporal Degener. 2015;16:216–23.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.